Stocks in News: Epizyme (NASDAQ:EPZM), Cempra (NASDAQ:CEMP), Talmer Bancorp (NASDAQ:TLMR), Pfizer Inc. (NYSE:PFE), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)

On Tuesday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $17.85. HC Wainright reiterated their buy rating on shares of Epizyme Inc. (NASDAQ:EPZM) in a research note released on 30 April.

Cempra, Inc. (NASDAQ:CEMP) in last trading activity advanced 1.79% to close at $34.73. Company weekly performance is 9.63% while its quarterly performance stands at 31.75%. Cempra, Inc. (NASDAQ:CEMP) is -16.57% away from its 52 week high. Cempra, Inc. (NASDAQ:CEMP) on April 30, 2015, released financial results for the quarter ended March 31, 2015 and provided an update on recent corporate developments. For the quarter ended March 31, 2015, Cempra reported a net loss of $17.4 million, or $0.41 per share, compared to a net loss of $17.0 million, or $0.51 per share, for the same period in 2014. An increase in R&D and G&A expenses were mitigated by a $10.0 million non-clinical milestone payment from our Japanese partner, Toyama, which was booked in the first quarter as revenue. Research and development expense in the first quarter was $26.1 million, an increase of 59.1% compared to the same quarter in 2014.

On last trading day Talmer Bancorp, Inc. (NASDAQ:TLMR) advanced 0.13% to close at $15.72. Its volatility for the week is 1.60% while volatility for the month is 1.72%. Talmer Bancorp, Inc. (NASDAQ:TLMR) monthly performance is -0.32%. On 30 April, Due to recent acquisitions, Troy, Mich.-based Talmer Bancorp Inc. (NASDAQ:TLMR) reported a sharp drop in net income for the first quarter of 2015 compared with the same quarter in 2014. The holding company of Talmer Bank and Trust earned $9.4 million in the first quarter of 2015 net income compared with $38.2 million for the first quarter of 2014. The company earned $12.5 million for the fourth quarter of 2014.

On last trading day Pfizer Inc. (NYSE:PFE) fell -0.53% to close at $33.78. Its volatility for the week is 1.21% while volatility for the month is 1.32%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is -2.94%. Pfizer Inc. (NYSE:PFE) announced that it has acquired a minority equity interest in a privately-held Dutch biopharmaceutical company AM-Pharma B.V.

On Tuesday shares of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) closed at $9.76. Company’s sales growth for last 5 years was 3.60% and EPS growth for next 5 years is recorded as 10.27%. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) announces that today R$ 157 million (about US$52 million) in funds repatriated by Brazil’s Federal Prosecutor as a result of Operation Lava Jato were made available for the Company. This is the first reimbursement of funds to the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

*